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2. Experimental design, materials and methods
2.1. Cell culture and reagents
The human colorectal HCT116 cell line (obtained from ATCC)
was maintained (at a conﬂuency not greater than 90%) in DMEM
supplemented with 10% heat-inactivated FBS and 1× penicillin/
streptomycin at 37 °C with 5% CO2.
2.2. Crosslinking and sonication of cells for ChIP assay
Low passage (b5) HCT116 cells were grown in T150 cm2 ﬂasks and
removed from the plate using 0.05% trypsin–EDTA and 1× PBS, and
spun down at 1000 g at 4 °C for 5min. Excess trypsin/PBSwas aspirated
and the cell pellet was resuspended to a density of 1 × 107 cells/mL in
PBS. Methanol-free formaldehyde (16% stock) was added dropwise to
a 0.5% ﬁnal concentration and gently nutated at room temperature for
10 min. To ensure that no cell clumps formed, the cell suspension was
pipetted up and down throughout several times during the crosslinking
step. Crosslinking was quenched through the dropwise addition of gly-
cine to a ﬁnal concentration of 0.125Mand gently nutated at room tem-
perature for 10 min. The crosslinked cell suspension was then spun
down at 800 g at 4 °C for 5 min. The cell pellet was washed twicethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Flowchart showing the pipeline used for ChIP-seq data analysis. See text for details.
251R.P. McNamara et al. / Genomics Data 7 (2016) 250–255(spun down at 1000 g at 4 °C for 5 min) in cold PBS to eliminate excess
formaldehyde and glycine.
The cell pellet was then resuspended in cold Farnham lysis buffer
(5 mM piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES) pH 8.0,
85 mM KCl, 1 mM PMSF, 1× EDTA-free protease inhibitor, 0.5% NP-
40) to a ﬁnal cell density of 1 × 107 cells/mL and dounce homogenized
(10 strokes) in a 1mL dounce homogenizer using a loose pestle (Whea-
ton). The cell suspension was then nutated at 4 °C for 30 min and spun
down at 1000 g at 4 °C for 10min. These combined steps are to separate
cytosolic components from the nucleus. The supernatant (cytosol) was
discarded and the pellet (nuclei) was resuspended in cold Szak's RIPA
buffer (50 mM Tris–HCl pH 8.0, 150 mM NaCl, 2.5 mM EDTA, 1% NP-
40, 0.1% SDS, 0.5% deoxycholic acid, 1× EDTA-free protease inhibitor,
1 mM PMSF) to a ﬁnal density of 2.5 × 107 cells/mL and dounce homog-
enized (10 strokes) in a 1 mL dounce homogenizer using a tight pestle
(Wheaton). The nuclear lysate was then transferred to thin-walled
1.5 mL TPX tubes (Diagenode) for a ﬁnal volume of 250 μL per tube
(this is a critical limit that must be respected). Samples were then son-
icated until DNA was fragmented to an average distribution of about
200–300 bp using a water bath Bioruptor (Diagenode) for a total of
45 cycles (30 s on and 30 s off). To further ensure sonication efﬁciency,
we allowed a 20min cool-down of the water bath after every 20 cycles.
To verify that DNAwas fragmented to the appropriate size (200–300 bp
average distribution), a fraction of lysate was reverse crosslinked, the
DNA was puriﬁed and run on a 1.5% agarose gel stained with ethidium
bromide alongside a 100 bp ladder at 5 V/cm.
2.3. ChIP assay
Dynabeads Protein G (10004D, Life Technologies) (70 μL of slurry
per ChIP) were equilibrated with RIPA buffer. 4 μg of each antibody di-
luted in 500 μL of RIPA (see McNamara et al. [1]) was conjugated to
beads at room temperature for 1 h. Antibody-coated beads were then
blocked with 0.3 mg/mL BSA diluted in RIPA at 4 °C for 1 h. Then, the
sonicated nuclear lysate (from point 2.2) was added to the blocked
antibody-coated beads and nutated at 4 °C for 2 h. Given the low levels
of ChIP recovery for some of the 7SK snRNP components, we optimized
the amount of sonicated cell nuclei used per ChIP assay as follows:
2.5 × 107 cell nuclei for Pol II, H3K4me3, H3K4me1, and H3K27ac; and
5.0 × 107 cell nuclei for KAP1, Cdk9, Hexim1, and Larp7. Unbound nucle-
ar lysate was discarded and beads were washed twice with the follow-
ing cold buffers:
1. RIPA buffer (see above),
2. Low salt buffer (1% NP-40, 20 mM Tris–HCl pH 8.0, 150 mM NaCl,
0.1% SDS, 0.5% deoxycholic acid, 2.5 mM EDTA, 1 mM PMSF),
3. High salt buffer (1% NP-40, 20 mM Tris–HCl pH 8.0, 500 mM NaCl,
0.1% SDS, 0.5% deoxycholic acid, 2.5 mM EDTA, 1 mM PMSF),
4. LiCl buffer (1% NP-40, 20mM Tris HCl pH 8.0, 250mM LiCl, 0.1% SDS,
0.5% deoxycholic acid, 2.5 mM EDTA, 1 mM PMSF),
5. 1× Tris–HCl EDTA buffer (TE).
After washing, complexes were eluted off the beads using elution
buffer (1% SDS and 100mMNaHCO3) at 65 °C for 30min,with intermit-
tent vortexing. Protein-DNA complexes were decrosslinked using
decrosslinking buffer (50 mM Tris–HCl pH 6.8, 500 mM NaCl, 5 mM
EDTA, 0.5 mg/mL Proteinase K) at 60 °C for 4 h. DNA was then puriﬁed
using the Zymo ChIP DNA Clean and Concentrator Kit (Zymo Research).
2.4. ChIP DNA quality control
All ChIP DNA samples were quantiﬁed for concentration using the
Qubit® 2.0 Fluorometer (Thermo Fisher Scientiﬁc). A small fraction of
input and ChIP DNAwas used to test for enrichment at the NFKBIA pro-
moter (a Pol II paused gene) prior to library preparation and sequenc-
ing. The non-Pol II paused gene GREB1 was used as a negative control
[1–2]. Given that our ChIP DNA samples showed enrichment at the PolII paused NFKBIA promoter-proximal region (but not at the GREB1 neg-
ative control gene), we submitted our samples for high-throughput
sequencing.
2.5. ChIP DNA library preparation and sequencing
10–20 ng DNA (Input or ChIP from Point 2.3) were submitted to the
McDermott Center Sequencing Core at UT SouthwesternMedical Center
for library preparation and high-throughput sequencing using the
NextSeq500 (Illumina). Samples were end repaired, 3′-end adenylated
and barcodedwithmultiplex adapters (Applied Biosystems). After puri-
ﬁcation with Ampure XP beads (Beckman Coulter), samples were PCR
ampliﬁed for 15 cycles, size selected with Ampure XP beads, and quan-
tiﬁed on the Agilent 2100 BioAnalyzer. Emulsion PCR was then per-
formed and beads enriched on the EZ-Bead system. Each sample
yielded 2.5–5.0 × 107 total reads of 50 nt, depending on the sample.
For each sample, ~70–80% of unique reads mapped to the human ge-
nome (GRCh37/hg19).
3. Data analysis and results
Fig. 1 shows a detailed ﬂowchart description of the steps/tools used
for data analysis.
3.1. Computational analysis and data transformation
All scriptingwas performed using Python 2.7.6. All ChIP-seq binding
events were loaded into a customMySQL database to allow for efﬁcient
comparisons of multiple factors' binding loci. Fastq ﬁles obtained from
the sequencing core were ﬁrst checked for quality using Fastqc, and
then trimmed of any adapters, barcodes, and low-quality sequences
using the Fastx toolkit (Fig. 1). For mapping and sorting, the ChIP-seq
output was aligned to the reference human genome (GRCh37/hg19)
using Bowtie v1.0.0 [3], allowing 1 mismatch (−v 1). Sequences
aligning to multiple locations in the reference genome were discarded.
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converted to binary (.bam) using Samtools [4]. For ChIP-seq peak call-
ing, the .sam ﬁles for all ChIP-seq marks were analyzed for binding
events using peak calling in theMACS2 software [5].When determining
peaks, duplicate read alignments were discarded to avoid ampliﬁcation
artifacts from the sequencing PCR. All ChIP-seq ﬁles were normalized to
input sequencing ﬁles.
3.2. ChIP-seq data visualization
MACS2 was run in the callpeak mode with the –B and –SPMR ﬂags
set to generate signal pileup tracks in bedGraph format on a per million
reads basis. This allows for direct comparison between individual tracks,
regardless of any differences in the sequencing depth. The bedgraph
ﬁles were converted to BigWig ﬁles using a custom script based on the
University of California at Santa Cruz (UCSC) tool ‘bedGraphToBigWig’.
The pileup tracks (.BigWig ﬁles) were visualized using Integrative Ge-
nomics Viewer (IGV) [6]. The normalized pileup tracks also served as
the input for many data visualizations as noted below.
3.3. Generation of ChIP-seq heatmaps
HOMER [7] annotatePeaks.pl was used to generate density matrices
using normalized bedGraph pileup tracks of ChIP-seq marks as input.
The –hist ﬂag was set with a parameter of 50 bp bins and the –ghist
ﬂag was also set to generate a density matrix. After density matrixes
were generated they were fed into Cluster 3.0 to generate a .cdt ﬁle. A
custom script was then used to rank the resulting .cdt ﬁle in order of de-
creasing density. We took the Pol II matrix and sorted it by decreasing
total density and then clustered all other ChIP-seq matrices to the
same sort order as Pol II. The resulting .cdt matrices were then fed into
Java TreeView 3.0 [8] to generate visual heatmaps.
3.4. Generation of ChIP-seq metagene plots
HOMER [7] annotatePeaks.pl was used to generate metagene plots
based on the average proﬁle of a series of ChIP-seqmarks in normalized
bedGraph pileup tracks. The –hist ﬂag was set using 50 bp bins for all
metagene proﬁles. Plots were centered on the TSS and extending the in-
dicated window (e.g. ±1 kb (−size 2000)).
3.5. GRO-seq analysis
We analyzed the nascent RNA-sequencing data (GRO-seq) generat-
ed by the Espinosa laboratory in the HCT116 cell line [9] to compare
transcription statuswith levels of Pol II and KAP1-7SK snRNP occupancy
at promoter-proximal regions. We ranked RefSeq genes located in the
positive strand in the human genome based on decreasing sense tran-
script levels surrounding the TSS. We then sorted the ChIP-seq datasets
of Pol II, KAP1, Cdk9, Hexim1, and Larp7 based on ranked GRO-seq data.
GRO-seq Fastq ﬁles [9] were downloaded from the ftp server of the
European Bioinformatics Institute (EBI) (ftp://ftp.sra.ebi.ac.uk/vol1/
fastq/) and then aligned using Bowtie v1.1.2 allowing for up to two
mismatches (−n 2) resulting in a sam output ﬁle (−S). Sam ﬁles
were then converted into sorted bam using Samtools v1.3 and fur-
ther converted into strand speciﬁc genome coverages using bedtools
(genomeCoverageBed). Entire documented analysis and parameters
can be found on our Github (https://github.com/Dorsolab/GD_
GenomicsData_Analysis).
3.6. Genome-wide factor distribution and co-occupancy analysis
To characterize the genome-wide distribution of the 7SK snRNP, we
employed an unbiased ChIP-seq approach to localize the individual
components: Larp7 (constitutively bound to the 3′ of 7SK RNA),
Hexim1 (7SK RNA-binding protein that tethers P-TEFb to the 7SKsnRNP), and Cdk9 (the kinase subunit of P-TEFb) [10]. We interrogated
the locations of these three components to identify with high-
conﬁdence genomic domains marked by the 7SK snRNP (as opposed
to the detection of individual subunits not assembled on the snRNP).
We also examined the distribution of KAP1 to determine if it co-
occupies genomic domains with the 7SK snRNP, possibly forming a
KAP1-7SK snRNP complex [1].
To identify KAP1 and 7SK snRNP target genes we searched for KAP1,
Hexim1, Larp7, and Cdk9 narrow peaks (as deﬁned by MACS) at
promoter-proximal regions of genes listed in the UCSC RefSeq database
(30,180 unique TSS). For the occupancy analysis, we deﬁned a broader
promoter-proximal region window than others have used (−250 to
+1000 bp from the TSS). These thresholds were selected because we
found 13,048 genes having a Pol II summit using a narrow window
(−250 to+250 bp from the TSS) and 4268 additional genes containing
a Pol II summit, in addition to an H3K4me3 peak, at+250 to+1000 bp
from the TSS (Fig. 2A). It is unclear, however, whether this increase in
genes containing paused Pol II in the broader window is due to inaccu-
rate TSS annotations and/or that in some genes Pol II pauses further
downstream from the +100 site, as the Pol II metagene analysis
indicates (see below). Therefore, the broader window (−250 to
+1000 bp from the TSS) was used for the co-occupancy analysis, to
more completely capture genes that have all the hallmarks of paused
Pol II, even though the pausing may appear downstream of more
restrictive bounds of a currently annotated TSS.
To identify genes targeted by KAP1, the 7SK snRNP, and Pol II (re-
ferred to as KEC target genes for KAP1-7SK snRNP early Elongation
Complex), we ﬁrst searched for Pol II summit locations in the broad
promoter-proximal region (−250 to+1000bp fromTSS) and analyzed
for co-occupancy of all KAP1-7SK snRNP components within a window
of −250 to +250 bp from the Pol II summit (narrow peak as deter-
mined by MACS) (Fig. 2B). This ﬁlter guarantees that the factors are
within a region where Pol II may realistically be considered paused,
and that they are all within a distance to interact (directly or indirectly)
with one another. We found 17,316 genes containing promoter-
proximal paused Pol II, 15,850 7SK snRNP target genes, 14,203 KAP1-
7SK snRNP target genes, and 12,211 KEC target genes (Fig. 2B and C).
This last number represents a large fraction of all RefSeq genes
(40.5% of all annotated genes and 70.5% of genes containing paused
Pol II), which prompted us to conclude that most active/paused
genes contain the KAP1-7SK snRNP complex in the promoter-
proximal region. Clearly, our combined experimental/computational
approach is underestimating the number of genes targeted by the
7SK snRNP, as can be seen by the lack of one of the three 7SK
snRNP components (probably due to technical difﬁculties with
ChIP-seq and/or the peak calling algorithm) (Fig. 2C).
3.7. A statistical analysis deﬁnes that KAP1, the 7SK snRNP, and Pol II are
enriched at promoter-proximal regions of active/paused genes
We found that the majority of KAP1 and components of the 7SK
snRNP complex mapped to promoter and promoter-proximal regions
of most genes containing paused Pol II [1]. Given our proposed role of
KAP1-7SK snRNP in promoting transcriptional elongation,we examined
the overlap of KAP1-7SK snRNP with Pol II outside the promoter-
proximal region, and calculated p-values for co-occupancy using the
hypergeometric density distribution with the phyper function in the R
stats package. For this analysis, we collapsed the entire genome into
250 bp bins, removing any region that corresponded to −250 to
+1000 bp from the TSS. Using this window, we found that paused Pol
II is present at the promoter-proximal region of 17,316 genes, and that
the KAP1-7SK snRNP is present at the promoter proximal-region of
14,203 genes, which represents an intersection of 12,211 genes. This
overlap is signiﬁcant at a p-value b 2.2204−16 (machine zero), as calcu-
lated using a hypergeometric density distribution. In addition,we found
paused Pol II at the promoter-proximal region of genes (n = 551)
Fig. 2. Strategy to identify 7SK snRNP, KAP1-7SK snRNP and KEC (KAP1-7SK snRNP early Elongation Complex) target genes in the human genome. (A) Search for Pol II peak summit in the
promoter-proximal region. (B) Search for factor co-occupancy in the−250 to+250 bp region from the Pol II peak summit at promoter-proximal regions. (C) Factor co-occupancy analysis
as explained in panel (B).
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genes having paused Pol II but no (or very low levels) KAP1-7SK
snRNP at these sites (p-value b 2.2204−16). Together, this indicates
that Pol II and the KAP1-7SK snRNP signiﬁcantly co-localize at
promoter-proximal regions.
3.8. KAP1 and the 7SK snRNP complex are deposited downstream of
paused Pol II
Given the high frequency of Pol II and KAP1-7SK snRNP co-
occupancy at promoter-proximal regions, we generated metagene
plots to deﬁne their average relative proximity to the TSS. The Pol IImetagene reveals that the average pause site occurs at about +100 bp
from the TSS (Fig. 3A and B), shifted slightly downstream of the paused
site originally identiﬁed in other Pol II Chip-chip or ChIP-seq datasets
[11–12]. These differences in Pol II pause site might be attributable to
the different species (humans or Drosophila) used in the experimental
approaches, number of genes being averaged depending on the spe-
cies analyzed, and/or mean signal densities. Higher resolution ap-
proaches like GRO-seq [13] and PRO-seq [14] concluded that Pol II
pauses, on average, at about +50 bp from the TSS thus showing
that our Pol II mean densities calculations might be accurate reﬂec-
tions of the broad distribution, and much lower resolution, obtained
with ChIP-seq.
Fig. 3.Mapping the location of KAP1 and the 7SK snRNP complex relative to the Pol II pause site. (A) Metagene analysis showing factor distribution surrounding the TSS with accurate
signal strengths. RPKM are Reads Per Kilobase of Transcript per Million mapped reads. (B) Metagene analysis showing factor distribution surrounding the TSS where the RPKM signal
was normalized to the maximum (Max) ChIP signal and expressed as percentage (%) for ease of comparison. (C) Metagene analysis showing the distribution of the chromatin
signatures (H3K4me3 and H3K27Ac) surrounding the TSS.
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7SK snRNP complex peaked downstream of the Pol II pause site,
mirroring the active chromatin signatures H3K4me3 and H3K27Ac
(Fig. 3C), indicating that the average KAP1-7SK snRNP peak falls about
100–150 bp downstream of the paused Pol II summit. Additionally, we
also noticed a fairly broad distribution pattern (+200–250 bp from
the TSS) for KAP1 and components of the 7SK snRNP complex (Fig. 3A
and B). This might be attributable to the different placement of KAP1-
7SK snRNP complexes at distinct groups of genes respective to the
TSS. Further experimental and computational work is needed to deﬁne
groups of genes with different positioning of the KAP1-7SK snRNP com-
plex respective to the TSS and its functional relationship to chromatin
architecture and transcriptional status.Fig. 4. Relationship between transcription activity, Pol II pausing, and recruitment of the KAP1-73.9. Relationship between transcription activity, Pol II pausing, and
recruitment of the KAP1-7SK snRNP to promoter-proximal regions
To deﬁne the relationship between Pol II pausing, KAP1-7SK snRNP
deposition at promoter-proximal regions and transcriptional levels,
we re-analyzed the nascent RNA-sequencing data (GRO-seq) generated
by the Espinosa laboratory [9]. After ranking RefSeq genes located in the
positive strand in the human genome based on decreasing levels of
transcription surrounding the TSS, we observed that the distribution
and levels of sense strand transcription mirror the occupancy levels of
paused Pol II and KAP1-7SK snRNP components (Fig. 4). Together, the
analysis indicates that paused Pol II and KAP1-7SK snRNP co-occupy
promoter-proximal regions of transcriptionally active/paused genesSK snRNP to promoter-proximal regions. GRO-seq shows only positive strand information.
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and KAP1-7SK snRNP at these sites.
4. Discussion
We described here an experimental approach to determine the oc-
cupancy of KAP1, the 7SK snRNP and Pol II in the human genome.
Using this collection of ChIP-seq datasets we demonstrated that the
transcriptional regulator KAP1 and the 7SK snRNP complex co-occupy
(with high frequency) promoter-proximal regions containing paused
Pol II. We propose that this collection will provide valuable information
for researchers studying mechanisms of transcriptional regulation, par-
ticularly Pol II pausing and pause release. Certainly, future experimental
and computational approaches are needed to further deﬁne if KAP1 re-
cruits the 7SK snRNP to most promoter-proximal regions containing
paused Pol II and whether the KAP1-7SK snRNP complex regulates
pause release genome-wide. Our main work has closely examined an-
notated transcripts but not divergent transcripts or non-coding RNAs.
Thus, it remains to be elucidated whether these unique non-coding
RNA species are also targeted by KAP1 and the 7SK snRNP or whether
they have unique regulatory strategies. Moreover, given that enhancers
play an important role in controlling gene activation from promoters
and because the 7SK snRNP appears to be recruited to these genomic
sites [15–16], future studies are needed to further deﬁne the role of
KAP1-7SK snRNP in controlling transcription from enhancers during
development and cell differentiation. Our work lays the foundation for
these future studies.
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